Frontier Biotechnologies Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
314
- Stock Symbol
-
688221
- Share Price
-
$2.04
- (As of Thursday Closing)
Frontier Biotechnologies General Information
Description
Frontier Biotechnologies Inc is engaged in the Research, development, production, and marketing of inventive drugs that address unmet clinical needs.
Contact Information
Website
www.frontierbiotech.comCorporate Office
- Building 7, No. 5, Gande Road
- Science Park, Jiangning District
- Nanjing, Jiangsu
- China
Corporate Office
- Building 7, No. 5, Gande Road
- Science Park, Jiangning District
- Nanjing, Jiangsu
- China
Frontier Biotechnologies Stock Performance
As of 12-Nov-2026, Frontier Biotechnologies’s stock price is $2.04. Its current market cap is $765M with 375M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.04 | $2.08 | $1.81 - $4.38 | $765M | 375M | 12.4M | -$0.01 |
Frontier Biotechnologies Financials Summary
As of 30-Sep-2026, Frontier Biotechnologies has a trailing 12-month revenue of $51.9M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 899,128 | 920,911 | 471,508 | 429,670 |
| Revenue | 51,915 | 17,158 | 18,044 | 16,149 |
| EBITDA | (5,573) | (31,428) | (21,380) | (39,708) |
| Net Income | (5,195) | (37,275) | (28,065) | (46,498) |
| Total Assets | 243,339 | 225,579 | 248,235 | 301,911 |
| Total Debt | 55,962 | 58,442 | 57,933 | 54,323 |
Frontier Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Frontier Biotechnologies Comparisons
Industry
Financing
Details
Frontier Biotechnologies Competitors (13)
One of Frontier Biotechnologies’s 13 competitors is CStone Pharmaceuticals, a Formerly VC-backed company based in Suzhou, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CStone Pharmaceuticals | Formerly VC-backed | Suzhou, China | ||||
| Mabworks Biotech | Venture Capital-Backed | Beijing, China | ||||
| JW Therapeutics | Formerly VC-backed | Shanghai, China | ||||
| BeOne Medicines | Formerly PE-Backed | Beijing, China | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA |
Frontier Biotechnologies Signals
Frontier Biotechnologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Frontier Biotechnologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Frontier Biotechnologies FAQs
-
When was Frontier Biotechnologies founded?
Frontier Biotechnologies was founded in 2013.
-
Where is Frontier Biotechnologies headquartered?
Frontier Biotechnologies is headquartered in Nanjing, China.
-
What is the size of Frontier Biotechnologies?
Frontier Biotechnologies has 314 total employees.
-
What industry is Frontier Biotechnologies in?
Frontier Biotechnologies’s primary industry is Drug Discovery.
-
Is Frontier Biotechnologies a private or public company?
Frontier Biotechnologies is a Public company.
-
What is Frontier Biotechnologies’s stock symbol?
The ticker symbol for Frontier Biotechnologies is 688221.
-
What is the current stock price of Frontier Biotechnologies?
As of 12-Nov-2026 the stock price of Frontier Biotechnologies is $2.04.
-
What is the current market cap of Frontier Biotechnologies?
The current market capitalization of Frontier Biotechnologies is $765M.
-
What is Frontier Biotechnologies’s current revenue?
The trailing twelve month revenue for Frontier Biotechnologies is $51.9M.
-
Who are Frontier Biotechnologies’s competitors?
CStone Pharmaceuticals, Mabworks Biotech, JW Therapeutics, BeOne Medicines, and Sarepta Therapeutics are some of the 13 competitors of Frontier Biotechnologies.
-
What is Frontier Biotechnologies’s annual earnings per share (EPS)?
Frontier Biotechnologies’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process